RSSRetrospective Analysis

Characterization of the 2016–2017 Dermatology Standardized Letter of Recommendation

Characterization of the 2016–2017 Dermatology Standardized Letter of Recommendation

| March 1, 2018

by Rebecca F. Wang, BA; Myron Zhang, MD; Allireza Alloo, MD; Thomas Stasko, MD; Jordan E. Miller, BA; and Jessica A. Kaffenberger, MD Ms. Wang and Drs. Zhang and Kaffenberger are with the Division of Dermatology, Department of Internal Medicine, The Ohio State University Wexner Medical Center in Columbus, Ohio. Dr. Alloo is with the […]

Continue Reading

Eyebrow Contouring with Hyaluronic Acid Gel Filler Injections

Eyebrow Contouring with Hyaluronic Acid Gel Filler Injections

| February 1, 2018

by Hamzah Mustak, FCOphth (SA); Danica Fiaschetti, LVN, COA; Adit Gupta, MD; and Robert Goldberg, MD Dr. Mustak is with the University of Cape Town Groote Schuur Hospital in Cape Town, Western Cape, South Africa. Drs. Mustak, Fiaschetti, Gupta, and Goldberg are with the Stein Eye Institute, University of California in Los Angeles, California.    Funding: […]

Continue Reading

A Retrospective Analysis Comparing the New Standardized Letter of Recommendation in Dermatology with the Classic Narrative Letter of Recommendation

| September 1, 2016

aJessica A. Kaffenberger, MD; bJoy Mosser, MD; aGrace Lee, MD; aLlana Pootrakul, MD, PhD; bKatya Harfmann, MD; aStephanie Fabbro, MD; bEsteban Fernandez Faith, MD; aDavid Carr, MD; aAlisha Plotner, MD; aMatthew Zirwas, MD; aBenjamin H. Kaffenberger, MD aDepartment of Internal Medicine, Division of Dermatology, The Ohio State University Wexner Medical Center, Columbus, Ohio; bDepartment of […]

Continue Reading

Dermatological Adverse Events Associated with Topical Brimonidine Gel 0.33% in Subjects with Erythema of Rosacea A Retrospective Review of Clinical Studies

| August 1, 2015

aAnna D. Holmes, PhD; aKimberly A. Waite, BS; aMichael C. Chen, PhD; aKiruthi Palaniswamy, PharmD; aThomas H. Wiser, PharmD; bZoe D. Draelos, MD; cElyse S. Rafal, MD; dW. Philip Werschler, MD; aAlison E. Harvey, PhD aGalderma Laboratories, LP, Fort Worth, Texas; bDermatology Consulting Services, High Point, North Carolina; cDermResearchCenter of New York, Inc., Stony Brook, […]

Continue Reading

Biologic Safety in Psoriasis Review of Long-Term Safety Data

| February 1, 2015 | 0 Comments

Yasaman Mansouri, MD; Gary Goldenberg, MD The Icahn School of Medicine at Mount Sinai, Department of Dermatology, New York, New York Disclosure: Dr. Mansouri’s research fellowship at the Icahn School of Medicine at Mount Sinai is supported by the Geoffrey Dowling Fellowship, a grant from the British Association of Dermatologists (United Kingdom). Dr. Goldenberg has […]

Continue Reading

Clinical Efficacy of Short Contact Topical 5-Fluorouracil in the Treatment of Keratoacanthomas A Retrospective Analysis

| November 1, 2014 | 0 Comments

Bobbye J. Thompson, MD, Med; Margaret Ravits, MD; David N. Silvers, MD Drs. Thompson and Ravits are from the Department of Dermatology, Columbia University Medical Center, New York, New York. Dr. Silvers is from Department of Pathology, Columbia University Medical Center, New York, New York. Disclosure: The authors report no relevant conflicts of interest Abstract […]

Continue Reading

Impact of Baseline Disease Severity Over 26 and 52 Weeks of Treatment with Calcitriol Ointment 3µg/g in Patients with Mild-to-moderate Plaque Psoriasis

| February 16, 2012 | 0 Comments

Mark Lebwohl, MD; Norman Preston, PhD; Ronald W. Gottschalk, MD, FRCPC Dr. Lebwohl is from Mount Sinai School of Medicine, New York, New York; Drs. Preston and Gottschalk are from Galderma Laboratories, L.P., Fort Worth, Texas

Continue Reading